Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Mirtazapine for fibromyalgia in adults

This is not the most recent version

Information

DOI:
https://doi.org/10.1002/14651858.CD012708Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 29 June 2017see what's new
Type:
  1. Intervention
Stage:
  1. Protocol
Cochrane Editorial Group:
  1. Cochrane Pain, Palliative and Supportive Care Group

Copyright:
  1. Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Patrick Welsch

    Health Care Center for Pain Medicine and Mental Health, Saarbrücken, Germany

  • Kathrin Bernardy

    Department of Pain Medicine, BG University Hospital Bergmannsheil GmbH, Ruhr University Bochum, Bochum, Germany

  • Sheena Derry

    Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics), University of Oxford, Oxford, UK

  • R Andrew Moore

    Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics), University of Oxford, Oxford, UK

  • Winfried Häuser

    Correspondence to: Department of Psychosomatic Medicine and Psychotherapy, Technische Universität München, München, Germany

    [email protected]

Contributions of authors

WH, SD, and RAM drafted the protocol. All authors had input into the protocol development and agreed the final version.

Sources of support

Internal sources

  • Oxford Pain Relief Trust, UK.

    General institutional support

External sources

  • National Institute for Health Research (NIHR), UK.

    NIHR Cochrane Programme Grant: 13/89/29 ‐ Addressing the unmet need of chronic pain: providing the evidence for treatments of pain

Declarations of interest

PW: none known. PW is a specialist pain physician and manages patients with fibromyalgia.

KB: none known; KB is a clinical psychologist and manages patients with fibromyalgia. She is member of the committee of the German guideline on fibromyalgia.

SD: none known.

RAM has received grant support from Grünenthal relating to individual patient level analyses of trial data regarding tapentadol in osteoarthritis and back pain (2015). He has received honoraria for attending boards with Menarini concerning methods of analgesic trial design (2014), with Novartis (2014) about the design of network meta‐analyses, and RB on understanding pharmacokinetics of drug uptake (2015). He has received honoraria from Omega Pharma (2016) and Futura Pharma (2016) for providing advice on trial and data analysis methods.

WH is a specialist in general internal medicine, psychosomatic medicine and pain medicine, who treats patients with fibromyalgia. He is a member of the medical board of the German Fibromyalgia Association. He is the head of the steering committee of the German guideline on fibromyalgia and a member of the steering committee of the European League Against Rheumatism (EULAR) update recommendations on the management of fibromyalgia. He received speaking fees for one educational lecture from Grünenthal (2015) on pain management.

Acknowledgements

Institutional support is provided by the Oxford Pain Relief Trust.

The National Institute for Health Research (NIHR) is the largest single funder of Cochrane Pain, Palliative and Supportive Care (PaPaS). Disclaimer: the views and opinions expressed herein are those of the review authors and do not necessarily reflect those of the NIHR, National Health Service (NHS) or the Department of Health.

This protocol is based on a template developed in collaboration with Cochrane Neuromuscular Diseases and Cochrane Musculoskeletal. The editorial process is managed by PaPaS.

Version history

Published

Title

Stage

Authors

Version

2018 Aug 06

Mirtazapine for fibromyalgia in adults

Review

Patrick Welsch, Kathrin Bernardy, Sheena Derry, R Andrew Moore, Winfried Häuser

https://doi.org/10.1002/14651858.CD012708.pub2

2017 Jun 29

Mirtazapine for fibromyalgia in adults

Protocol

Patrick Welsch, Kathrin Bernardy, Sheena Derry, R Andrew Moore, Winfried Häuser

https://doi.org/10.1002/14651858.CD012708

Keywords

MeSH

PICOs

Population
Intervention
Comparison
Outcome

The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.

See more on using PICO in the Cochrane Handbook.